Aspen Pharmacare HoldingsJSE:APN +1.06%74 Pretax Margin % is 6.76% as of Dec. 2025, which is 56% below its 10-year median of 15.52. GuruFocus rates JSE:APN with a GF Score™ of 74/100 and a GF Value™ of R178.11 (Modestly Undervalued). The stock has 10 warning signs investors should review. Among 954 Drug Manufacturers companies, Aspen Pharmacare Holdings ranks worse than 70.55% on this metric.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Aspen Pharmacare Holdings Pretax Margin % Related Terms
Aspen Pharmacare Holdings Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:APN vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Pharmacare Holdings Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Aspen Pharmacare Holdings's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspen Pharmacare Holdings (JSE:APN) has a Pretax Margin % of 6.76% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aspen Pharmacare Holdings and its competitors. This is 56% below median its historical median of 15.52. According to the industry distribution chart, Aspen Pharmacare Holdings ranks #673 out of 954 companies in the Drug Manufacturers industry, placing it in the top 70.5%.
Is Aspen Pharmacare Holdings' Pretax Margin % too high?
Aspen Pharmacare Holdings' current Pretax Margin % of 6.76% is 56% below median its 10-year median of 15.52. The Drug Manufacturers industry median Pretax Margin % is 7.30. Aspen Pharmacare Holdings' value of 6.76% is 7.3% below this industry median. Based on the distribution chart, Aspen Pharmacare Holdings ranks #673 out of 954 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Aspen Pharmacare Holdings has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Aspen Pharmacare Holdings ranks #673 out of 954 companies for Pretax Margin %. This places Aspen Pharmacare Holdings in the lower half of its industry. The industry median Pretax Margin % is 7.30. Aspen Pharmacare Holdings' value of 6.76% is 7.3% below this benchmark. While the company's 10-year median is 15.52 vs. the industry median of 7.30, Aspen Pharmacare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspen Pharmacare Holdings's current Pretax Margin % of 6.76% is 7.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Aspen Pharmacare Holdings and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Pharmacare Holdings's current Pretax Margin % is 6.76%, which is 56% below median its own 10-year median of 15.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.11, compared to a current price of R158.55 — trading 11% below its estimated fair value. The current Pretax Margin % is 6.76%, which is 56% below median its 10-year median of 15.52 and 7.3% below the Drug Manufacturers industry median of 7.30. Aspen Pharmacare Holdings' overall GF Score™ is 74/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current Pretax Margin % is 6.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued.
The current stock price of R158.55 is trading 11% below its estimated GF Value™ of R178.11.
GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.
Key valuation signals for JSE:APN:
Pretax Margin %: 6.76% (56% below median its 10-year median of 15.52)
GF Value™: R178.11 vs. price of R158.55 (11% below fair value)
Industry Position: 7.3% below the Drug Manufacturers median (#673 of 954)
No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
74GF Score
Get the complete analysis for JSE:APN
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:APN has been successfully added to your 
